-
Je něco špatně v tomto záznamu ?
Socio-medical studies of individuals self-treating with helminths provide insight into clinical trial design for assessing helminth therapy
A. Venkatakrishnan, JT. Sarafian, K. Jirků-Pomajbíková, W. Parker
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
Odkazy
PubMed
34737071
DOI
10.1016/j.parint.2021.102488
Knihovny.cz E-zdroje
- MeSH
- cizopasní červi fyziologie MeSH
- helmintoterapie * MeSH
- klinické zkoušky jako téma metody MeSH
- lidé MeSH
- samoléčba MeSH
- výzkumný projekt * trendy MeSH
- zánět MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
The virtually complete loss of intestinal worms, known as helminths, from Western society has resulted in elimination of a range of helminth-induced morbidities. Unfortunately, that loss has also led to inflammation-associated deficiencies in immune function, ultimately contributing to widespread pandemics of allergies, autoimmunity, and neuropsychiatric disorders. Several socio-medical studies have examined the effects of intentional reworming, or self-treatment with helminths, on a variety of inflammation-related disorders. In this study, the latest results from ongoing socio-medical studies are described. The results point toward two important factors that appear to be overlooked in some if not most clinical trials. Specifically, (a) the method of preparation of the helminth can have a profound effect on its therapeutic efficacy, and (b) variation between individuals in the effective therapeutic dosage apparently covers a 10-fold range, regardless of the helminth used. These results highlight current limits in our understanding of the biology of both hosts and helminths, and suggest that information from self-treatment may be critical for clinical evaluation of the benefits and limits of helminth therapy.
Department of Surgery Duke University School of Medicine Durham NC USA
Duke Global Health Institute Duke University and Duke University Medical Center Durham NC 27710 USA
Faculty of Science University of South Bohemia 370 05 České Budějovice Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22019048
- 003
- CZ-PrNML
- 005
- 20220804135320.0
- 007
- ta
- 008
- 220720s2022 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.parint.2021.102488 $2 doi
- 035 __
- $a (PubMed)34737071
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Venkatakrishnan, Aarushi $u Department of Surgery, Duke University School of Medicine, Durham, NC, USA
- 245 10
- $a Socio-medical studies of individuals self-treating with helminths provide insight into clinical trial design for assessing helminth therapy / $c A. Venkatakrishnan, JT. Sarafian, K. Jirků-Pomajbíková, W. Parker
- 520 9_
- $a The virtually complete loss of intestinal worms, known as helminths, from Western society has resulted in elimination of a range of helminth-induced morbidities. Unfortunately, that loss has also led to inflammation-associated deficiencies in immune function, ultimately contributing to widespread pandemics of allergies, autoimmunity, and neuropsychiatric disorders. Several socio-medical studies have examined the effects of intentional reworming, or self-treatment with helminths, on a variety of inflammation-related disorders. In this study, the latest results from ongoing socio-medical studies are described. The results point toward two important factors that appear to be overlooked in some if not most clinical trials. Specifically, (a) the method of preparation of the helminth can have a profound effect on its therapeutic efficacy, and (b) variation between individuals in the effective therapeutic dosage apparently covers a 10-fold range, regardless of the helminth used. These results highlight current limits in our understanding of the biology of both hosts and helminths, and suggest that information from self-treatment may be critical for clinical evaluation of the benefits and limits of helminth therapy.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a klinické zkoušky jako téma $x metody $7 D002986
- 650 _2
- $a cizopasní červi $x fyziologie $7 D006376
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zánět $7 D007249
- 650 12
- $a výzkumný projekt $x trendy $7 D012107
- 650 _2
- $a samoléčba $7 D012651
- 650 12
- $a helmintoterapie $7 D061147
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sarafian, Joshua T $u Department of Surgery, Duke University School of Medicine, Durham, NC, USA
- 700 1_
- $a Jirků-Pomajbíková, Kateřina $u Institute of Parasitology, Biology Centre, Czech Academy of Sciences, 370 05 České Budějovice, Czech Republic; Faculty of Science, University of South Bohemia, 370 05 České Budějovice, Czech Republic
- 700 1_
- $a Parker, William $u Department of Surgery, Duke University School of Medicine, Durham, NC, USA; Duke Global Health Institute, Duke University and Duke University Medical Center, Durham, NC 27710, USA. Electronic address: William.Parker@WilliamParkerLab.org
- 773 0_
- $w MED00008651 $t Parasitology international $x 1873-0329 $g Roč. 87, č. - (2022), s. 102488
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34737071 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135314 $b ABA008
- 999 __
- $a ok $b bmc $g 1822593 $s 1170291
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 87 $c - $d 102488 $e 20211101 $i 1873-0329 $m Parasitology international $n Parasitol Int $x MED00008651
- LZP __
- $a Pubmed-20220720